查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511312

到 2030 年高性能醫用塑膠的全球市場預測：按原料、應用和地區分類

High Performance Medical Plastics Market Forecasts to 2030 - Global Analysis By Raw Material, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2024年全球高性能醫用塑膠市場規模將達11.5億美元，預計2030年將達到20.8億美元，預測期內複合年成長率為10.4%。

高性能醫用塑膠是專門為滿足醫療應用的嚴格要求而設計的先進聚合物材料。這些材料具有卓越的強度、耐用性和生物相容性，非常適合用於醫療設備、植入和手術器械。高性能醫用塑膠具有耐滅菌方法、與各種體液相容以及精密成型能力等特性，可製造複雜且可靠的醫療設備。

根據世界衛生組織 2021 年的數據，每年約有 130 萬人死於交通事故，另有 2,000 至 5,000 萬人遭受非致命傷害，其中許多人因受傷而殘疾。

環境永續性意識不斷增強

隨著人們對傳統塑膠對生態影響的認知不斷增強，包括醫療保健在內的行業正在轉向永續的替代品。高性能醫用塑膠以其耐用性、生物相容性和滅菌能力而聞名，正在迅速被採用。這些材料提供了引人注目的解決方案，滿足醫療保健行業嚴格的品質和安全標準，同時最大限度地減少對環境的影響。製造商正在投資研發，以進一步增強這些塑膠的永續性，從而推動市場成長。

材料缺陷的風險

高性能醫用塑膠 (HPMP) 的進步受到材料失效風險的挑戰。這些材料由於具有生物相容性、耐用性和耐化學性等優異特性，在各種醫療應用中極為重要。確保醫療應用惡劣條件下的可靠性至關重要。然而，材料失效可能會導致性能下降、潛在的患者傷害以及製造商成本增加。長期接觸刺激性化學物質、重複滅菌程序以及使用過程中的機械應力等因素會導致失敗的風險。

開發患者專用植入

患者專用植入的開發是高性能醫用塑膠興起的主要動力。這些植入根據個別患者的解剖規格量身定做，與傳統的通用植入相比，具有卓越的貼合性和性能。高性能醫用塑膠因其多功能性、生物相容性和耐用性而在這種定製過程中發揮關鍵作用。這些材料可以經過精確設計來模仿人體組織的特性，確保在體內達到最佳整合，同時提供必要的結構支撐。其他優點包括輕質設計、耐腐蝕和靈活性，使其成為各種醫療應用的理想選擇。

成本限制

成本限制是高性能醫用塑膠進步的主要障礙。這些材料通常需要特殊的配方和製造程序，以滿足醫療產業嚴格的安全和性能標準。在降低成本的同時達到這些標準是一項重大挑戰。優質的原料、精密的製造流程以及嚴格的品管措施都導致了更高的製造成本。因此，具有卓越性能的創新醫用塑膠的開發和採用可能會因平衡負擔能力和功能性的需要而受到限制。

COVID-19 的影響：

COVID-19大流行對高性能醫用塑膠市場產生了重大影響，因為對人工呼吸器、面罩和醫用包裝等醫療設備的需求激增，導致其生產中使用的高性能醫用塑膠得到提振。 。然而，由於關閉和限制而導致的全球供應鏈中斷給原料採購和生產能力帶來了挑戰。整體而言，疫情帶來了挑戰，但也加速了創新，凸顯了高性能醫用塑膠在醫療保健應用中的重要角色。

預計聚碸市場在預測期內將成為最大的細分市場

預計聚碸領域在預測期內將佔據最大佔有率。聚碸是一種高性能熱塑性塑膠，由於其優異的性能正在徹底改變醫用塑膠市場。其優異的強度、耐化學性和生物相容性使其成為各種醫療應用的理想選擇。在手術器械、導管和血液透析機膜等醫療設備中，聚碸具有無與倫比的耐用性和可靠性。它們能夠承受重複的滅菌週期而不會劣化，確保產品的使用壽命和安全性，這在醫療保健環境中至關重要。

預計藥物輸送產業在預測期內複合年成長率最高

預計藥物輸送產業在預測期內複合年成長率最高。高性能醫用塑膠以其生物相容性、耐用性和多功能性而聞名，是藥物傳輸系統的理想材料。這些塑膠可以經過精確設計，以更高的效率和精度封裝和輸送藥物。此外，實現標靶藥物傳輸可以最大限度地減少全身副作用並改善患者的治療結果。先進的製造技術能夠生產複雜的藥物輸送裝置，例如根據特定治療需求量身定做的植入、微球和貼片。

比最大的地區

塑膠零件擴大用於醫療設備，因為它們比金屬和玻璃等傳統材料更通用、更輕且更具成本效益。醫療技術的進步要求材料能夠滿足嚴格的監管標準，同時具有卓越的性能，例如生物相容性、耐用性和耐滅菌製程。此外，高性能醫用塑膠符合這些標準，這使得它們對於製造從導管到手術器械等各種醫療設備至關重要。

複合年成長率最高的地區：

預計亞太地區在預測期內將出現強勁成長。嚴格的法規要求在醫療器材與設備中使用安全、優質的材料，這促使製造商選擇先進的醫療級塑膠。這些法規確保醫療設備符合嚴格的安全和性能標準，推動該地區對高性能醫用塑膠的需求。專注於減少醫療保健相關感染的監管工作正在刺激抗菌和無菌塑膠在醫療應用中的採用。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球高性能醫用塑膠市場：依原料分類

  • 聚碸
  • 聚丙烯
  • 聚碳酸酯
  • 聚苯硫
  • 其他

第6章 全球高性能醫用塑膠市場：依應用分類

  • 藥物輸送
  • 義肢/植入
  • 醫療設備/工具
  • 醫療拋棄式
  • 其他

第7章 全球高性能醫用塑膠市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第8章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第9章 公司概況

  • BASF SE
  • Bayer AG
  • DuPont
  • Eastman Chemical Company
  • Evonik Industries AG
  • Lubrizol Corporation
  • Mitsubishi Chemical Corporation
  • Raumedic AG
  • Rochling SE & Co. KG
  • Saint-Gobain Performance Plastic
  • The Chemours Company
  • Victrex PLC
Product Code: SMRC26690

According to Stratistics MRC, the Global High Performance Medical Plastics Market is accounted for $1.15 billion in 2024 and is expected to reach $2.08 billion by 2030 growing at a CAGR of 10.4% during the forecast period. High-performance medical plastics are advanced polymer materials specifically engineered to meet stringent requirements for medical applications. These materials exhibit exceptional strength, durability, and biocompatibility, making them ideal for use in medical devices, implants, and surgical instruments. High-performance medical plastics offer properties such as resistance to sterilization methods, compatibility with various bodily fluids, and precision molding capabilities, enabling the creation of intricate and reliable medical devices.

According to the WHO 2021, around 1.3 million people die each year due to road traffic crashes and around 20 to 50 million more people suffer non-fatal injuries, with many experiencing a disability due to their injury.

Market Dynamics:

Driver:

Increasing awareness about environmental sustainability

With increasing awareness about the ecological repercussions of traditional plastics, industries, including healthcare, are pivoting towards sustainable alternatives. High performance medical plastics, renowned for their durability, biocompatibility, and sterilization capabilities, are witnessing a surge in adoption. These materials offer a compelling solution, aligning with the healthcare sector's stringent quality and safety standards while minimizing environmental impact. Manufacturers are investing in research and development to enhance the sustainability profile of these plastics further, catalyzing market growth.

Restraint:

Risk of material failure

The risk of material failure poses a significant challenge to the advancement of High Performance Medical Plastics (HPMP). These materials are crucial in various medical applications due to their superior properties like biocompatibility, durability, and resistance to chemicals. Ensuring their reliability under the demanding conditions of medical use is essential. However, material failures can lead to compromised performance, potential harm to patients, and increased costs for manufacturers. Factors such as long-term exposure to harsh chemicals, repeated sterilization processes, and mechanical stresses during use contribute to the risk of failure.

Opportunity:

Development of patient specific implants

The development of patient-specific implants has been a significant driving force behind the rise of high-performance medical plastics. These implants are tailored to individual patients' anatomical specifications, offering better compatibility and performance compared to traditional, one-size-fits-all implants. High-performance medical plastics play a crucial role in this customization process due to their versatility, biocompatibility, and durability. These materials can be precisely engineered to mimic the properties of human tissues, ensuring optimal integration within the body while providing necessary structural support. Additionally, they offer advantages such as lightweight design, resistance to corrosion, and flexibility, making them ideal for a wide range of medical applications.

Threat:

Cost constraints

Cost constraints pose a significant hindrance to the advancement of high-performance medical plastics. These materials often require specialized formulations and production processes to meet stringent safety and performance standards demanded by the medical industry. Achieving these standards while keeping costs low presents a considerable challenge. High-quality raw materials, precise manufacturing techniques, and rigorous quality control measures all contribute to elevated production expenses. As a result, the development and adoption of innovative medical plastics with superior performance characteristics may be limited by the need to balance affordability with functionality.

Covid-19 Impact:

The Covid-19 pandemic has significantly impacted the High Performance Medical Plastics market due to the surge in demand for medical equipment such as ventilators, face shields, and medical packaging has boosted the demand for high-performance medical plastics used in their manufacturing. However, disruptions in the global supply chain due to lockdowns and restrictions have led to challenges in sourcing raw materials and hindered production capacities. Overall, while the pandemic has posed challenges, it has also accelerated innovation and highlighted the critical role of high-performance medical plastics in healthcare applications.

The Polysulfone segment is expected to be the largest during the forecast period

Polysulfone segment is expected to be the largest during the forecast period. Polysulfone, a high-performance thermoplastic, is revolutionizing the medical plastics market due to its exceptional properties. Its superior strength, chemical resistance, and biocompatibility make it ideal for various medical applications. In medical devices, such as surgical instruments, catheters, and hemodialysis membranes, polysulfone offers unmatched durability and reliability. Its ability to withstand repeated sterilization cycles without degradation ensures product longevity and safety, crucial in healthcare settings.

The Drug Delivery segment is expected to have the highest CAGR during the forecast period

Drug Delivery segment is expected to have the highest CAGR during the forecast period. High performance medical plastics, known for their biocompatibility, durability, and versatility, serve as ideal materials for drug delivery systems. These plastics can be precisely engineered to encapsulate and deliver pharmaceuticals with increased efficiency and accuracy. Moreover, they enable targeted drug delivery, minimizing systemic side effects and improving patient outcomes. Advanced manufacturing techniques allow for the production of intricate drug delivery devices, such as implants, microspheres, and patches, tailored to specific therapeutic needs.

Region with largest share:

North America region commanded the largest share of the market during the extrapolated period, as medical devices are increasingly incorporating plastic components due to their versatility, lightweight nature, and cost-effectiveness compared to traditional materials like metal or glass. The advancements in medical technology require materials that can meet stringent regulatory standards while offering superior performance characteristics such as biocompatibility, durability, and resistance to sterilization processes. Furthermore, high-performance medical plastics fulfill these criteria, making them indispensable in the production of various medical devices ranging from catheters to surgical instruments.

Region with highest CAGR:

Asia Pacific region is estimated to witness robust growth over the projection time frame. Stringent regulations mandating the use of safe and high-quality materials in medical devices and equipment are prompting manufacturers to opt for advanced medical-grade plastics. These regulations ensure that medical devices meet strict safety and performance standards, driving the demand for high-performance medical plastics in the region. Regulatory initiatives focused on reducing healthcare-associated infections are spurring the adoption of antimicrobial and sterilizable plastics in medical applications.

Key players in the market

Some of the key players in High Performance Medical Plastics market include BASF SE, Bayer AG, DuPont, Eastman Chemical Company, Evonik Industries AG, Lubrizol Corporation, Mitsubishi Chemical Corporation, Raumedic AG, Rochling SE & Co. KG, Saint-Gobain Performance Plastic, The Chemours Company and Victrex PLC.

Key Developments:

In March2024, Evonik Industries AG and Vland Biotech Begin Joint Venture. The venture aims to expand the market presence of their livestock probiotics in Greater China and develop new products. Evonik's biotech platform is dedicated to creating biosolutions for healthier living. It innovates at the crossroads of chemistry, biotechnology, pharmacology, and data science.

In June2023, The Lubrizol Corporation will invest over $150 million (about ₹1,200 crore) across different projects in India. According to the specialty chemicals maker, the investments will be made into setting up CPVC (chlorinated polyvinyl chloride) resin plant in Vilayat, doubling the capacity at its site in Dahej in Gujarat and opening a grease lab in Navi Mumbai.

Raw Materials Covered:

  • Polysulfone
  • Polypropylene
  • Polycarbonate
  • Polyphenylene Sulfide
  • Other Raw Materials

Applications Covered:

  • Drug Delivery
  • Prosthetics & Implants
  • Medical Equipment & Tools
  • Medical Disposables
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global High Performance Medical Plastics Market, By Raw Material

  • 5.1 Introduction
  • 5.2 Polysulfone
  • 5.3 Polypropylene
  • 5.4 Polycarbonate
  • 5.5 Polyphenylene Sulfide
  • 5.6 Other Raw Materials

6 Global High Performance Medical Plastics Market, By Application

  • 6.1 Introduction
  • 6.2 Drug Delivery
  • 6.3 Prosthetics & Implants
  • 6.4 Medical Equipment & Tools
  • 6.5 Medical Disposables
  • 6.6 Other Applications

7 Global High Performance Medical Plastics Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 BASF SE
  • 9.2 Bayer AG
  • 9.3 DuPont
  • 9.4 Eastman Chemical Company
  • 9.5 Evonik Industries AG
  • 9.6 Lubrizol Corporation
  • 9.7 Mitsubishi Chemical Corporation
  • 9.8 Raumedic AG
  • 9.9 Rochling SE & Co. KG
  • 9.10 Saint-Gobain Performance Plastic
  • 9.11 The Chemours Company
  • 9.12 Victrex PLC

List of Tables

  • Table 1 Global High Performance Medical Plastics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 3 Global High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 4 Global High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 5 Global High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 6 Global High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 7 Global High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 8 Global High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 9 Global High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 10 Global High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 11 Global High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 12 Global High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 13 Global High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 14 North America High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
  • Table 15 North America High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 16 North America High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 17 North America High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 18 North America High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 19 North America High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 20 North America High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 21 North America High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 22 North America High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 23 North America High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 24 North America High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 25 North America High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 26 North America High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 27 Europe High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
  • Table 28 Europe High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 29 Europe High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 30 Europe High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 31 Europe High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 32 Europe High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 33 Europe High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 34 Europe High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 35 Europe High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 36 Europe High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 37 Europe High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 38 Europe High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 39 Europe High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 40 Asia Pacific High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
  • Table 41 Asia Pacific High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 42 Asia Pacific High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 43 Asia Pacific High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 44 Asia Pacific High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 45 Asia Pacific High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 46 Asia Pacific High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 47 Asia Pacific High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 48 Asia Pacific High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 49 Asia Pacific High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 50 Asia Pacific High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 51 Asia Pacific High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 52 Asia Pacific High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 53 South America High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
  • Table 54 South America High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 55 South America High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 56 South America High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 57 South America High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 58 South America High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 59 South America High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 60 South America High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 61 South America High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 62 South America High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 63 South America High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 64 South America High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 65 South America High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 66 Middle East & Africa High Performance Medical Plastics Market Outlook, By Country (2022-2030) ($MN)
  • Table 67 Middle East & Africa High Performance Medical Plastics Market Outlook, By Raw Material (2022-2030) ($MN)
  • Table 68 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polysulfone (2022-2030) ($MN)
  • Table 69 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polypropylene (2022-2030) ($MN)
  • Table 70 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polycarbonate (2022-2030) ($MN)
  • Table 71 Middle East & Africa High Performance Medical Plastics Market Outlook, By Polyphenylene Sulfide (2022-2030) ($MN)
  • Table 72 Middle East & Africa High Performance Medical Plastics Market Outlook, By Other Raw Materials (2022-2030) ($MN)
  • Table 73 Middle East & Africa High Performance Medical Plastics Market Outlook, By Application (2022-2030) ($MN)
  • Table 74 Middle East & Africa High Performance Medical Plastics Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 75 Middle East & Africa High Performance Medical Plastics Market Outlook, By Prosthetics & Implants (2022-2030) ($MN)
  • Table 76 Middle East & Africa High Performance Medical Plastics Market Outlook, By Medical Equipment & Tools (2022-2030) ($MN)
  • Table 77 Middle East & Africa High Performance Medical Plastics Market Outlook, By Medical Disposables (2022-2030) ($MN)
  • Table 78 Middle East & Africa High Performance Medical Plastics Market Outlook, By Other Applications (2022-2030) ($MN)